Biospace | Patient Daily

Biospace

Patient Daily | Feb 5, 2026

FDA lifts hold on Intellia's phase III ATTR gene editing trial

Patient Daily | Feb 5, 2026

Proactive strategies urged for FDA inspection readiness in life sciences manufacturing

Patient Daily | Feb 5, 2026

CytoDyn’s ex-CEO sentenced to prison and fined over securities fraud

Patient Daily | Feb 5, 2026

Roche reports strong phase II results for obesity drug candidate CT-388

Patient Daily | Feb 5, 2026

Sarepta faces challenges as new Duchenne muscular dystrophy gene therapies near market

Patient Daily | Feb 4, 2026

Leaders urged to prioritize subtraction of old tasks for successful goal execution

Patient Daily | Feb 4, 2026

Lilly partners with Seamless Therapeutics on $1.12B+ gene editing deal for hearing loss

Patient Daily | Feb 4, 2026

Cellares raises $257M for expansion of automated cell therapy manufacturing

Trending

Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families

A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’

A. D. Alderman | Jun 3, 2026

New study says TikTok content may normalize illicit vaping among youth as Trump Administration ramps up enforcement

Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions